Minju Sparks
Nurse Practitioner · Chula Vista, CANPI 1629599345
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,228 of the $6,078 with a category attached, or 86.0%. 29 manufacturers reported payments, led by Edwards Lifesciences at 29.1% of the total. Reporting peaked in 2023 at $2,612 and has fallen 94.4% since, to $147 in 2025. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 134 payments — averaging $45.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$2K
- Abbott$893
- Amgen$666
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$333
- Cvrx, Inc.$270
- Boston Scientific$258
- plus $2K from 23 others
What the payments were for
- Travel & lodging$85014%
- Food & beverage$5,22886%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 12 | $1,766 |
| Abbott | 16 | $893 |
| Amgen | 40 | $666 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $333 |
| Cvrx, Inc. | 6 | $270 |
| Boston Scientific | 4 | $258 |
| Medtronic | 2 | $239 |
| Abiomed | 3 | $233 |
| AstraZeneca | 6 | $212 |
| Kestra Medical Technology Services, Inc. | 4 | $171 |
| Actelion Pharmaceuticals US, Inc. | 1 | $148 |
| Heartflow, Inc. | 1 | $127 |
| E.r. Squibb & Sons, L.L.C. | 2 | $123 |
| Cardiva Medical, Inc. | 2 | $120 |
| Johnson & Johnson(2 entities) | 3 | $112 |
| Novartis | 3 | $81 |
| Merck | 3 | $74 |
| Inari Medical, Inc. | 1 | $34 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $28 |
| Lexicon Pharmaceuticals, Inc. | 1 | $27 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $23 |
| Bridgebio Pharma, Inc. | 1 | $21 |
| Pfizer | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Chiesi USA, Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Novo Nordisk | 1 | $16 |
| Janssen Scientific Affairs, LLC | 1 | $16 |
| Biotronik Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,078 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 11 | $103 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Chula Vista
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.